# RNN 1st Gen Model Aflac Incorporated Accident & health insurance

Stock predictor AI models:
81.54% successful of 65 deals
$ 53.67 Last close price
at 29-oct-2021


Model's trade recommendations 3.83% Return for period

8.24% Annual return

$35.11B Market Cap

β 0.94  


Model (following trade recommendations)


Underlying stock

S&P 500

Return for period 3.83%
52wk return 9.62%
52wk Range
Sortino ratio 2.24
Sharpe ratio 1.49
Norm. RMSE 6.01%
Downside risk 3.45%
Volatility 0.00%
  • 1.04 (2.31%) Div (Yield)
  • HOLD Analysts consensus recommendation

Aflac, Inc. is a Fortune 500 company, providing financial protection to more than 50 million people worldwide. When a policyholder or insured gets sick or hurt, Aflac pays cash benefits fairly, promptly, and often in one day for eligible claims, directly to the insured (unless assigned otherwise). American Family Life pioneered the introduction of a cancer policy after identifying the need to lift the financial burden of cancer patients and their families. For more than six decades, Aflac voluntary insurance policies have given policyholders the opportunity to focus on recovery, not financial stress.

Industry sector: Finance

Sector classification: Accident & health insurance

Deep Learning based analysis and prediction model for Aflac Incorporated (AFL) stock is a 1st Generation Non-linear Autoregresive with exogenous variable(s) (NARX) model based on the Recurrent Neural Network architecture.

Model is in the production pipeline since April 29, 2015.

Market data for AFL model training are being downloaded from the Quandl premium datasets on a daily basis.
Risks related to the novel coronavirus disease 2019 (COVID-19) caused by the virus named “SARS-CoV-2” are accounted for in this model in the form of the historical data coincided with outbreaks and other global events in the past used to train ML prediction model for AFL.

Model is being retrained on a daily basis.

Float 756M
P/E 12.46
Shares Outstanding 779M
% Held by Insiders 3.00%
% Held by Institutions 35.72%
EPS (last reported FY) $3.40
EPS (last reported Q) $1.05
EPS, estimated (last reported Q) $0.97
Total revenues $22 B
Net income $5 B